Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AQUILAVIE LAUNCHES SAFE AND PAINLESS 'AQ LOLLIPOP' DUAL-USE COVID-19 RAPID TEST KIT FOR KIDS IN DISCOUNTED BACK-TO-SCHOOL BUNDLE 2022-08-29 14:00
Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results 2022-08-24 07:30
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head 2022-08-23 07:30
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17 2022-08-22 10:05
Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA 2022-08-22 08:10
Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines 2022-08-19 11:29
JOYSBIO HAS DEVELOPED NEW MONKEYPOX RAPID TESTS 2022-08-17 14:30
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17 2022-08-12 21:39
FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID 2022-08-09 00:00
Catalytic Investment to Improve Community Health Care for Millions Across Africa 2022-08-08 19:07
ECOLAB NAMES GREGORY LUKASIK SENIOR VICE PRESIDENT AND MARKET HEAD FOR SOUTHEAST ASIA 2022-08-05 09:00
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya 2022-08-03 14:00
Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet 2022-08-02 08:00
PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS 2022-08-01 09:03
Global Fund Reports Significant Progress in Breaking Down Human Rights-Related Barriers to HIV and TB Services 2022-08-01 08:59
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants 2022-07-27 07:00
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan 2022-07-26 20:05
Vaccines alone aren't enough to combat AMR, claims new WHO report 2022-07-23 00:30
VIRALEZE™ Nasal Spray Protects Against Highly Infectious Omicron in Viral Challenge Model - Before or After Viral Exposure 2022-07-20 17:45
U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older 2022-07-20 05:46
1 8 9 10 11 12 71